Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan

Affiliations

¹ Departments of Diagnostic Radiology * and.
² Neurosurgery, † Graduate School of Medicine, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.

Comment

Shunji Mugikura et al. Radiology. 2017 Jul.

. 2017 Jul;284(1):301-303.

doi: 10.1148/radiol.2017170252.

¹ Departments of Diagnostic Radiology * and.
² Neurosurgery, † Graduate School of Medicine, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.

No abstract available

Comment in

Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response.
Haller S, Barkhof F, Thomas D, Lovblad KO, Golay X, Zaharchuk G. Haller S, et al. Radiology. 2017 Jul;284(1):301-303. doi: 10.1148/radiol.2017170252. Radiology. 2017. PMID: 28896007 No abstract available.

Arterial Spin Labeling Perfusion of the Brain: Emerging Clinical Applications.
Haller S, Zaharchuk G, Thomas DL, Lovblad KO, Barkhof F, Golay X. Haller S, et al. Radiology. 2016 Nov;281(2):337-356. doi: 10.1148/radiol.2016150789. Radiology. 2016. PMID: 27755938 Review.
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response.
Haller S, Barkhof F, Thomas D, Lovblad KO, Golay X, Zaharchuk G. Haller S, et al. Radiology. 2017 Jul;284(1):301-303. doi: 10.1148/radiol.2017170252. Radiology. 2017. PMID: 28896007 No abstract available.